The current PE ratio of LIVN can't be determined, as the TTM EPS of -$4.07 is negative. The most recent PE ratio recorded for LivaNova was 39.58 in December 2024.
Over the last eight years, the average PE ratio of LivaNova has been 256.69. Over the past eight years, LIVN's PE ratio was at its highest in the Sep 2023 quarter at 1,057.6, with a price of $52.88 and an EPS of $0.05. The Dec 2024 quarter recorded the bottom point at 39.58, with a price of $46.31 and an EPS of $1.17.
Maximum annual decrease: -74.76% in 2024
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 39.58 | -74.76% | $46.31 | $1.17 |
2023 | 156.79 | N/A | $51.74 | $0.33 |
2022 | N/A | N/A | $55.54 | -$1.61 |
2021 | N/A | N/A | $87.43 | -$2.68 |
2020 | N/A | N/A | $66.21 | -$7.18 |
2019 | N/A | N/A | $75.43 | -$3.26 |
2018 | N/A | N/A | $91.47 | -$3.91 |
2017 | N/A | N/A | $79.92 | -$0.52 |
2016 | N/A | N/A | $44.97 | -$1.29 |
2015 | N/A | N/A | N/A | $2.19 |
2014 | N/A | N/A | N/A | $2.02 |
2013 | N/A | N/A | N/A | $1.68 |
2012 | N/A | N/A | N/A | $0.04 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | N/A | N/A | $39.28 | -$4.07 |
Dec 2024 | 39.58 | -66.85% | $46.31 | $1.17 |
Sep 2024 | 119.41 | N/A | $52.54 | $0.44 |
Jun 2024 | N/A | N/A | $54.82 | -$0.31 |
Mar 2024 | N/A | N/A | $55.94 | -$0.59 |
Dec 2023 | 156.79 | -85.17% | $51.74 | $0.33 |
Sep 2023 | 1,057.6 | N/A | $52.88 | $0.05 |
Jun 2023 | N/A | N/A | $51.43 | -$1.82 |
Mar 2023 | N/A | N/A | $43.58 | -$1.53 |
Dec 2022 | N/A | N/A | $55.54 | -$1.61 |
Sep 2022 | N/A | N/A | $50.77 | -$1.69 |
Jun 2022 | N/A | N/A | $62.47 | -$0.52 |
Mar 2022 | N/A | N/A | $81.83 | -$1.98 |
Dec 2021 | N/A | N/A | $87.43 | -$2.68 |
Sep 2021 | N/A | N/A | $79.19 | -$8.46 |
Stock name | PE ratio | Market cap |
---|---|---|
OFIX Orthofix Medical Inc | N/A | $482.32M |
LIVN LivaNova PLC | N/A | $2.4B |
The current price to earnings ratio of LIVN can't be calculated, as its EPS of -$4.07 is negative.
In the last eight years, the Sep 2023 quarter recorded the highest quarterly PE ratio at 1,057.6.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.